K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 740.00
-2.00 (-0.27%)
Jul 16, 2026, 10:12 AM JST
K Pharma,Inc. Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
8.62B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.00B | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 6.59B |
| CellSource | 3.67B |
| StemCell Institute | 2.81B |
| Immuno-Biological Laboratories | 1.00B |
| MEDINET | 998.00M |
| OncoTherapy Science | 808.00M |
| Carna Biosciences | 619.35M |
| Nano Holdings | 174.00M |